First FDA-Cleared Anti-Insomnia Device To Hit Market In 2017
This article was originally published in Clinica
Executive Summary
The US FDA has granted de novo clearance to Cerêve's Sleep System to treat insomnia, but the startup does not plan to launch the system until the second half of 2017. The software-controlled bedside device delivers cooling liquid in a pad worn on the forehead to help reduce frontal cortex "racing mind" activity.